tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eric Schmidt, 42 are a BUY (100%).
Analyst Eric Schmidt, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 45.51% that have a potential upside of 21.86% achieved within 588 days. Previously, Eric Schmidt worked at TD COWEN.
Eric Schmidt’s has documented 82 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on LEGN, Legend Biotech Corp at 16-Dec-2025.
Analyst best performing recommendations are on ALMS (ALUMIS).
The best stock recommendation documented was for BIIB (BIOGEN) at 1/2/2018. The price target of $338 was fulfilled within 1 day with a profit of $3.83 (1.15%) receiving and performance score of 11.46.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 30-Sep-2022
$300
$67.35 (28.95%)
$185
8 days ago
(12-Oct-2026)
6/8 (75%)
$74.29 (32.91%)
230
Buy Since 17-May-2026
$270
$37.35 (16.05%)
$240
11 days ago
(09-Oct-2026)
14/41 (34.15%)
$44.29 (19.62%)
181
Buy Since 04-May-2022
$256
$23.35 (10.04%)
$260
12 days ago
(08-Oct-2026)
57/88 (64.77%)
$37.57 (17.20%)
182
Sell Since 17-Mar-2026
$175
$-57.65 (-24.78%)
$150
1 months 10 days ago
(10-Sep-2026)
0/3 (0%)
$-40.43 (-18.77%)
Buy Since 15-May-2026
$245
$12.35 (5.31%)
$225
1 months 17 days ago
(03-Sep-2026)
3/7 (42.86%)
$20.49 (9.13%)
87
What Year was the first public recommendation made by Eric Schmidt?
